O
Owkin
AI to Find the Right Treatment for Every Patient
Paris, France (US office in NYC)
400+
About Owkin
Industry:
AI Drug Discovery/Diagnostics
Founded:
2016
Founders:
Thomas Clozel, Gilles Wainrib
Status:
Private
Funding & Growth
Total Raised:
$300M+
Valuation:
$1B+
Stage:
Series C
Key Investors:
Sanofi
BMS
Fidelity
GV
✓ Pros
- • Federated learning pioneer
- • Strong pharma partnerships
- • European AI leader
- • Good work-life balance
- • Interesting multi-modal research
✗ Cons
- • Paris HQ (timezone for US)
- • Smaller US presence
- • Path to profitability
- • Competitive AI market